Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Dable Habib J
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   107,192    

Indirect Shares

  0      
Direct Value   $18,378,074    

Indirect Value

  $0      
Total Shares   107,192      
Total Value   $18,378,074      


Acceleron Pharma Inc
 $17,597,938 Blueprint Medicines Corp
 $780,136 Acceleron Pharma Inc
 $17,597,938 Blueprint Medicines Corp
 $780,136
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Acceleron Pharma Inc XLRN CEO and President, Dir... 2021-07-02 98,450 2016-12-01 0    Premium*  
            Blueprint Medicines Corp BPMC 2024-06-12 8,742 2022-06-23 0    Premium*  
* Premium Members only  

Records found :    21         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BPMC Blueprint Medicines Corp   –       •      –    2022-06-23 4 A $0.00 $0 D/D 3,900 3,900 0 -
BPMC Blueprint Medicines Corp   –       •      –    2023-06-21 4 A $0.00 $0 D/D 2,600 6,500 0 -
BPMC Blueprint Medicines Corp   –       •      –    2024-06-12 4 A $0.00 $0 D/D 2,242 8,742 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2016-12-01 4 A $0.00 $0 D/D 62,800 62,800 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2018-03-01 4 A $0.00 $0 D/D 18,100 80,900 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2018-12-04 4 AS $51.54 $671,610 D/D (12,675) 68,225 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2019-01-03 4 AS $40.85 $84,961 D/D (1,957) 66,268 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2019-01-25 4 A $0.00 $0 D/D 17,700 83,968 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2019-04-09 4 AS $44.23 $332,748 D/D (7,460) 76,508 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2019-09-10 4 AS $45.20 $254,412 D/D (5,625) 70,883 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2020-01-03 4 AS $51.24 $191,230 D/D (3,732) 67,151 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2020-01-22 4 A $0.00 $0 D/D 22,173 89,324 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2020-07-01 4 OE $35.04 $1,752,000 D/D 50,000 139,324 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2020-07-01 4 AS $93.53 $4,820,445 D/D (50,000) 89,324 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-01-04 4 D $124.31 $407,488 D/D (3,278) 86,046 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-01-05 4 AS $120.52 $515,774 D/D (4,258) 81,788 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-01-29 4 A $0.00 $0 D/D 16,662 98,450 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-07-01 4 AS $125.15 $7,326,588 D/D (57,814) 98,450 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-07-01 4 OE $35.04 $2,025,803 D/D 57,814 156,264 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-07-02 4 AS $126.69 $5,356,354 D/D (42,186) 98,450 0 -
XLRN Acceleron Pharma Inc CEO and President   •       •      –    2021-07-02 4 OE $35.04 $1,478,197 D/D 42,186 140,636 0 -

  21  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed